Founded in 1999, Astellas Venture Management is the corporate venture arm of Astellas Pharma and is headquartered in Menlo Park, California. The firm makes investment in privately owned early-stage biotechnology company focused on therapeutics programs and platform technologies for drug discovery and development.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Catamaran Bio | 23-Nov-2020 | Early Stage VC | 0000 | Drug Discovery | Startup | |
0000 00000000000 | 29-Oct-2020 | 000000000000 | 00000 | Monitoring Equipment | Generating Revenue | |
000 | 07-Sep-2020 | 00000 00000 | 0000 | Discovery Tools (Healthcare) | Generating Revenue | |
00000 000000000000 | 09-Jan-2020 | 00000 00000 | 0000 | Drug Delivery | Generating Revenue | |
0000000 | 20-Dec-2019 | 00000 00000 | 000.00 | Drug Discovery | Clinical Trials - Phase 1 | |
000000000 | 22-Nov-2019 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | |
0000 0000000000000 | 05-Nov-2019 | 00000 00000 | 0000 | Drug Discovery | Pre-Clinical Trials | 0000000000 000000000 00.0 |
000000 00000000000 | 17-Jun-2019 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 1 | |
eFFECTOR Therapeutics | 13-May-2019 | Later Stage VC | 000.00 | Drug Discovery | Generating Revenue | |
Twentyeight-Seven | 09-May-2019 | Early Stage VC | 000.00 | Biotechnology | Generating Revenue |
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Tacurion Pharma | 05-Oct-2020 | Out of Business | |
0000000 | 02-Oct-2020 | 000 | 0000 |
00000000 000000000 | 01-Oct-2019 | 000 00 00000000 | |
000000 000 | 11-Sep-2019 | 000000000000000000 | |
0000000 0000000000 | 23-May-2019 | 000 | 000.00 |
0000000 0000000000 | 14-Dec-2018 | 000000000000000000 | 00000 |
00000000 | 18-Oct-2018 | 000 | 0000 |
0000000000 | 28-Feb-2018 | 0000000000: 000000 | |
Mitobridge | 23-Jan-2018 | Merger/Acquisition | 00000 |
Viamet Group | 03-Jan-2018 | Buyout/LBO |
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialName | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Kazunori Maruyama Ph.D | President | 0 | Menlo Park, CA | ||
Hiromichi Kimura Ph.D | Investment Director | Menlo Park, CA | |||
Satoshi Konagai | Senior Investment Manager | Menlo Park, CA | |||
Tadayoshi Hirata | Senior Investment Manager | Menlo Park, CA | |||
Hikaru Saito Ph.D | Senior Investment Manager | Menlo Park, CA |
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
MPM Capital | 4 | 0 |
![]() |
![]() |
|
Novartis Venture Fund | 0 | 0 |
![]() |
![]() |
|
Osage University Partners | 0 |
![]() |
![]() |
||
Abingworth Management | 0 | 0 |
![]() |
![]() |
|
SV Health Investors | 0 | 0 |
![]() |
![]() |